175 related articles for article (PubMed ID: 8197804)
1. Association of primary sclerosing cholangitis with inflammatory bowel diseases: a prospective study.
Purrmann J; Mödder U; Cleveland S; Seibold F; Burchard A; Gemsa R; Lübke H
Z Gastroenterol; 1993 Nov; 31 Suppl 5():56-9. PubMed ID: 8197804
[No Abstract] [Full Text] [Related]
2. [Chronic inflammatory bowel disease and cardiovascular complications].
Rellecke P; Strauer BE
Med Klin (Munich); 2006 Mar; 101 Suppl 1():56-60. PubMed ID: 16802521
[TBL] [Abstract][Full Text] [Related]
3. [Coexistence of coeliac disease and inflammatory bowel disease in children].
Krawiec P; Pawłowska-Kamieniak A; Pac-Kożuchowska E; Mroczkowska-Juchkiewcz A; Kominek K
Pol Merkur Lekarski; 2016 Jan; 40(235):53-5. PubMed ID: 26891438
[TBL] [Abstract][Full Text] [Related]
4. The association of autoimmune disorders with inflammatory bowel disease.
Snook JA; de Silva HJ; Jewell DP
Q J Med; 1989 Sep; 72(269):835-40. PubMed ID: 2616728
[TBL] [Abstract][Full Text] [Related]
5. Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients.
Stephens J; Goldstein R; Crippin J; Husberg B; Holman M; Gonwa TA; Klintmalm G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1122-3. PubMed ID: 7680144
[No Abstract] [Full Text] [Related]
6. Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease.
Heikius B; Niemelä S; Lehtola J; Karttunen TJ
Am J Gastroenterol; 1999 Apr; 94(4):1062-9. PubMed ID: 10201484
[TBL] [Abstract][Full Text] [Related]
7. [Do patients with ulcerative colitis and also primary sclerosing cholangitis really have a higher risk of colorectal carcinoma?].
Keller R; Fischbach W
Z Gastroenterol; 1998 Nov; 36(11):1009-11. PubMed ID: 9880827
[No Abstract] [Full Text] [Related]
8. [Primary disease presentation associated with colitis patterns].
Lichert F
Z Gastroenterol; 2014 Mar; 52(3):256,258. PubMed ID: 24761444
[No Abstract] [Full Text] [Related]
9. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region).
Rönnblom A; Holmström T; Tanghöj H; Rorsman F; Sjöberg D
J Gastroenterol Hepatol; 2015 Aug; 30(8):1288-92. PubMed ID: 25777994
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
[TBL] [Abstract][Full Text] [Related]
11. [Crohn's disease, primary sclerosing cholangitis and antiphospholipid syndrome: an uncommon association].
Romdhane H; Karoui S; Serghini M; Boubaker J; Filali A
Tunis Med; 2009 May; 87(5):349-51. PubMed ID: 19927768
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
13. Non-calculus suppurative cholangitis in Danish patients with inflammatory bowel disease.
Rasmussen HH; Nørgård B; Olsen ML; Fonager K; Sørensen HT
Hepatogastroenterology; 2005; 52(61):115-8. PubMed ID: 15783009
[TBL] [Abstract][Full Text] [Related]
14. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].
Folwaczny C; Fricke H
Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690
[No Abstract] [Full Text] [Related]
15. [Primary sclerosing cholangitis and inflammatory intestinal disease].
Gil González I; González Hernández JM; Velicia Llames R
An Med Interna; 1992 Nov; 9(11):568. PubMed ID: 1467409
[No Abstract] [Full Text] [Related]
16. [Detection rate of primary sclerosing cholangitis in 160 cases of ulcerative colitis].
Liu X; Du ZG; Jia JD
Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):614. PubMed ID: 16092994
[No Abstract] [Full Text] [Related]
17. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR; Lashner BA; Hanauer SB
Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
[TBL] [Abstract][Full Text] [Related]
19. Cholestyramine treats primary sclerosing cholangitis-associated inflammatory bowel disease.
Pavlidis P; Heneghan M; Hayee B
J Crohns Colitis; 2015 Feb; 9(2):210. PubMed ID: 25518061
[No Abstract] [Full Text] [Related]
20. [Antibodies to neutrophilic granulocytes (p-ANCA): a further indication for a common origin of ulcerative colitis and primary sclerosing cholangitis?].
Jahn HU; Zeitz M
Z Gastroenterol; 1992 Jun; 30(6):441-2. PubMed ID: 1636280
[No Abstract] [Full Text] [Related]
[Next] [New Search]
